Company intelligence / Profile preview

Zhejiang Shengchuang Precision Medical Technology

Ownership: Private
Development stage: Other

Overview

Zhejiang Shengchuang Precision Medicine Technology is a private Chinese biotech company focused on developing mesenchymal stem cell therapies, with its lead program in Phase 1 clinical trials targeting COVID-19. The company’s main therapeutic focus includes infectious and respiratory diseases. No published clinical results are available as of the latest update.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Mesenchymal stem cell therapy
Industry: Biotech

Drug pipeline

1 asset

SC01009

Beyond the preview

Go deeper on Zhejiang Shengchuang Precision Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Shengchuang Precision Medical Technology.